Helicobacter pylori resistance to metronidazole and its association with virulence factors in a Moroccan population
Authors:
Open Access
- 21 June 2022
- journal article
- research article
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 42 (144) , 144
Abstract
Introduction: surveillance data on Helicobacter pylori (H. pylori) antibiotic susceptibilities in Morocco are limited, despite resistance being the key factor in treatment failure. Virulence factors of H. pyloriare associated with carcinogenesis and may be also associated with the efficacy of treatment. The aim of our study is to determine the prevalence of H. pylorimetronidazole resistance in a Moroccan population infected with H. pyloriand to study the impact of their virulence factors CagA and VacA on their resistance to metronidazole. Methods: the susceptibility to metronidazole of 185 isolates was determined by PCR. The isolates were also genotyped for CagA and VacA genes by PCR. Results: the metronidazole resistance rate was 62.70%. No association between resistance to metronidazole and social factors was detected. Regarding the virulence factors, we remarked that the moderate virulent strains s1/m2/i1/d1 with a CagA negative were the most resistant to metronidazole with a rate of 84% compared to the less virulent strains bearing the CagA negative VacA s2m2i2d2 genotype with a rate of 58% and the high virulent strains s1/m1/i1/d1-CagA positive with a rate of 47.06%. Conclusion: our study revealed a very high prevalence of resistance to metronidazole in our population. The resistance ability of H. pylorimaybe affected by its virulence intensity. H. pylorieradication regimens should therefore be reevaluated in this setting.Keywords
This publication has 28 references indexed in Scilit:
- Antibiotic susceptibility of Helicobacter pylori in IcelandInfectious Diseases, 2017
- Primary Antibiotic Resistance of Helicobacter pylori in ChinaDigestive Diseases and Sciences, 2017
- Helicobacter pylori Primary Antibiotic Resistance in 2015 in Morocco: A Phenotypic and Genotypic Prospective and Multicenter StudyMicrobial Drug Resistance, 2016
- Helicobacter pylori CagA and Gastric Cancer: A Paradigm for Hit-and-Run CarcinogenesisCell Host & Microbe, 2014
- Role of Deletion Located between the Intermediate and Middle Regions of the Helicobacter pylori vacA Gene in Cases of Gastroduodenal DiseasesJournal of Clinical Microbiology, 2009
- Analysis of drug resistance and virulence‐factor genotype of Irish Helicobacter pylori strains: is there any relationship between resistance to metronidazole and cagA status?Alimentary Pharmacology & Therapeutics, 2009
- A New Helicobacter pylori Vacuolating Cytotoxin Determinant, the Intermediate Region, Is Associated With Gastric CancerGastroenterology, 2007
- Differences in Genotypes ofHelicobacter pylorifrom Different Human PopulationsJournal of Bacteriology, 2000
- Importance of Helicobacter pylori cagA and vacAstatus for the efficacy of antibiotic treatmentGut, 2000
- Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pyloriJournal of Biological Chemistry, 1995